MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Leukemia, Hematologic, Blood
Actinium Pharmaceuticals, Inc. (NYSE:ATNM)*
Organization & Developments: Actinium Pharmaceuticals
Parents
Actinium Pharmaceuticals, Inc. (NYSE:ATNM)*
Children
*CD45 targeting antibody, Iomab-B
2020: Actinium Pharmaceuticals: Our Bullish View Is Intact On Promising Early Stage Results
2020: Actinium: Promises, Promises_seekingalpha.com
2021: The Verdict On Actinium Pharmaceuticals
2022: Actinium: 2 Catalysts Before End Of 2022 Could Boost Value
2022: Actinium: Overview Of A Promising Innovator_ seekingalpha.com
2022: Actinium's radiotherapy spooks AML in elderly patients, prompting a sweet tooth for regulatory approval
2022: IBI Blog On Actinium: You Should Look At The Windshield Rather Than Rearview_ seekingalpha.com
2024: Actinium Pharmaceuticals: Closer To Realizing Its Potential (Rating Upgrade)_seekingalpha.com
Jumps
*Key People: Actinium Pharmaceuticals
Finance & Acquisitions: Actinium Pharmaceuticals